These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32528661)

  • 1. Inhibition of
    Goyal S; Binnington B; McCarthy SDS; Desmaële D; Férrié L; Figadère B; Loiseau PM; Branch DR
    F1000Res; 2020; 9():268. PubMed ID: 32528661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.
    Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel amodiaquine derivatives potently inhibit Ebola virus infection.
    Sakurai Y; Sakakibara N; Toyama M; Baba M; Davey RA
    Antiviral Res; 2018 Dec; 160():175-182. PubMed ID: 30395872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus.
    McCarthy SD; Majchrzak-Kita B; Racine T; Kozlowski HN; Baker DP; Hoenen T; Kobinger GP; Fish EN; Branch DR
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004364. PubMed ID: 26752302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of protection against ebola virus from chloroquine in mice and hamsters.
    Falzarano D; Safronetz D; Prescott J; Marzi A; Feldmann F; Feldmann H
    Emerg Infect Dis; 2015 Jun; 21(6):1065-7. PubMed ID: 25988934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro.
    Gong M; Yang Y; Huang Y; Gan T; Wu Y; Gao H; Li Q; Nie J; Huang W; Wang Y; Zhang R; Zhong J; Deng F; Rao Y; Ding Q
    Antiviral Res; 2021 Oct; 194():105161. PubMed ID: 34391783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model.
    Dowall SD; Bosworth A; Watson R; Bewley K; Taylor I; Rayner E; Hunter L; Pearson G; Easterbrook L; Pitman J; Hewson R; Carroll MW
    J Gen Virol; 2015 Dec; 96(12):3484-3492. PubMed ID: 26459826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication.
    Luthra P; Liang J; Pietzsch CA; Khadka S; Edwards MR; Wei S; De S; Posner B; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Feb; 150():193-201. PubMed ID: 29294299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of sertindole, raloxifene and ibutamoren against transcription and replication-competent Ebola virus-like particles.
    Yoon YS; Jang Y; Hoenen T; Shin H; Lee Y; Kim M
    BMB Rep; 2020 Mar; 53(3):166-171. PubMed ID: 31964466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
    Wu W; Liu S
    Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
    Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication.
    Reynard O; Nguyen XN; Alazard-Dany N; Barateau V; Cimarelli A; Volchkov VE
    Viruses; 2015 Dec; 7(12):6233-40. PubMed ID: 26633464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.
    Salata C; Baritussio A; Munegato D; Calistri A; Ha HR; Bigler L; Fabris F; Parolin C; Palù G; Mirazimi A
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25933611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities.
    Du X; Zuo X; Meng F; Wu F; Zhao X; Li C; Cheng G; Qin FX
    Biochem Biophys Res Commun; 2020 Feb; 522(4):862-868. PubMed ID: 31806372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
    de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
    Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB
    PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.